ETRACS 2xMonthly Leveraged Alerian MLP
Infrastructure Index ETN Series B
ETRACS 2xMonthly Leveraged S&P MLP Index
ETN Series B
UBS Investment Bank announced that today is the first day of
trading on the NYSE Arca® for two new ETNs: the ETRACS 2xMonthly
Leveraged Alerian MLP Infrastructure Index ETN Series B
(NYSE Arca®:MLPQ) and the ETRACS 2xMonthly Leveraged
S&P MLP Index ETN Series B (NYSE Arca®:MLPZ). MLPQ
is linked to the monthly compounded 2x leveraged performance of the
Alerian MLP Infrastructure Index and MLPZ is linked to the monthly
compounded 2x leveraged performance of the S&P MLP Index.
About the Alerian MLP Infrastructure Index
The index, comprised of 22 energy infrastructure MLPs, is a
liquid, midstream-focused subset of the Alerian MLP index (NYSE:
AMZ). The index, whose constituents generally earn the majority of
their cash flow from the transportation and storage of energy
commodities, provides investors with a benchmark for the
infrastructure component of this emerging asset class. The index is
calculated using a capped, float-adjusted, capitalization-weighted
methodology that results in greater diversification of returns
versus a pure market capitalization-weighted index. The index
was created in March 2008 and has no performance history prior to
that date.
About the S&P MLP Index
The S&P MLP Index provides investors with exposure to
certain partnerships that trade on the NYSE and NASDAQ. The index
includes both master limited partnerships (MLPs) and publicly
traded limited liability companies (LLCs). The index was created
on September 6, 2007 and has no performance history prior to that
date.
More information:
MLPQ Prospectus Supplement
MLPZ Prospectus Supplement
About ETRACS
ETRACS ETNs are senior unsecured notes issued by UBS AG, are
traded on NYSE Arca, and can be bought and sold through a broker or
financial advisor. An investment in ETRACS ETNs is subject to a
number of risks, including the risk of loss of some or all of the
investor’s principal, and is subject to the creditworthiness of UBS
AG. Investors are not guaranteed any coupon or distribution amount
under the ETNs. We urge you to read the more detailed explanation
of risks described under “Risk Factors” in the applicable
prospectus supplement, or product supplement and pricing
supplement, as applicable, for the ETRACS ETN.
UBS AG has filed a registration statement (including a
prospectus and supplements thereto) with the Securities and
Exchange Commission, or SEC, for the offerings of securities to
which this communication relates. Before you invest, you should
read the applicable prospectus, pricing or product supplement,
dated as of various dates, and the prospectus dated June 12, 2015
to understand fully the terms of the securities and other
considerations that are important in making a decision about
investing in the ETRACS. The applicable offering document for each
ETRACS may be obtained by clicking on the ticker symbol of each
ETRACS under "more information" above. You may also get these
documents without cost by visiting EDGAR on the SEC website at
www.sec.gov. The securities related to the offerings are not
deposit liabilities and are not insured or guaranteed by the
Federal Deposit Insurance Corporation or any other governmental
agency of the United States, Switzerland or any other
jurisdiction.
About UBS
UBS is committed to providing wealthy, institutional and
corporate clients worldwide, as well as private clients in
Switzerland, with superior financial advice and solutions while
generating attractive and sustainable returns for shareholders. Its
strategy centers on its Wealth Management and Wealth Management
Americas businesses and its leading universal bank in Switzerland,
complemented by its Asset Management business and its Investment
Bank. These businesses share three key characteristics: they
benefit from a strong competitive position in their targeted
markets, are capital-efficient, and offer a superior structural
growth and profitability outlook. UBS's strategy builds on the
strengths of all of its businesses and focuses its efforts on areas
in which it excels, while seeking to capitalize on the compelling
growth prospects in the businesses and regions in which it
operates. Capital strength is the foundation of its success.
UBS is present in all major financial centers worldwide. It has
offices in more than 50 countries, with about 35% of its employees
working in the Americas, 36% in Switzerland, 17% in the rest of
Europe, the Middle East and Africa and 12% in Asia Pacific. UBS
Group AG employs about 60,000 people around the world. Its shares
are listed on the SIX Swiss Exchange and the New York Stock
Exchange (NYSE).
This material is issued by UBS AG and/or any of its subsidiaries
and/or any of its affiliates ("UBS"). Products and services
mentioned in this material may not be available for residents of
certain jurisdictions. Past performance is not necessarily
indicative of future results. Please consult the restrictions
relating to the product or service in question for further
information. Activities with respect to US securities are conducted
through UBS Securities LLC, a US broker/dealer. Member of SIPC
(http://www.sipc.org/).
ETRACS ETNs are sold only in conjunction with the relevant
offering materials. UBS has filed a registration statement
(including a prospectus, as supplemented by a prospectus
supplement, or product supplement and pricing supplement, for the
offering of the ETRACS ETNs) with the Securities and Exchange
Commission (the "SEC") for the offering to which this communication
relates. Before you invest, you should read these documents and any
other documents that UBS has filed with the SEC for more complete
information about UBS and the offering to which this communication
relates. You may get these documents for free by visiting EDGAR on
the SEC website at www.sec.gov. Alternatively, you can request the
prospectus and the applicable prospectus supplement, or product
supplement and pricing supplement, by calling toll-free (+1-877 387
2275). In the US, securities underwriting, trading and brokerage
activities and M&A advisor activities are provided by UBS
Securities LLC, a registered broker/dealer that is a wholly owned
subsidiary of UBS AG, a member of the New York Stock Exchange and
other principal exchanges, and a member of SIPC.
Alerian MLP Index, Alerian MLP Total Return Index, Alerian MLP
Infrastructure Index, Alerian MLP Infrastructure Total Return
Index, Alerian Natural Gas MLP Index, Alerian Natural Gas MLP Total
Return Index, AMZ, AMZX, AMZI, AMZIX, ANGI and ANGIX are trademarks
of Alerian and their use is granted under a license from
Alerian.
The S&P MLP Index (the “Index”) is a product of S&P Dow
Jones Indices LLC (“SPDJI”), and has been licensed for use by UBS
AG. Standard & Poor’s® and S&P® are registered trademarks
of Standard & Poor’s Financial Services LLC (“S&P”); Dow
Jones® is a registered trademark of Dow Jones Trademark Holdings
LLC (“Dow Jones”); and these trademarks have been licensed for use
by SPDJI and sublicensed for certain purposes by UBS AG. The ETRACS
2xMonthly Leveraged S&P MLP Index ETN are not sponsored,
endorsed, sold or promoted by SPDJI, Dow Jones, S&P, any of
their respective affiliates (collectively, “S&P Dow Jones
Indices”). S&P Dow Jones Indices makes no representation or
warranty, express or implied, to the owners of the ETRACS 2xMonthly
Leveraged S&P MLP Index ETN or any member of the public
regarding the advisability of investing in securities generally or
in the ETRACS 2xMonthly Leveraged S&P MLP Index ETN
particularly or the ability of the S&P MLP Index to track
general market performance. S&P Dow Jones Indices’ only
relationship to UBS AG with respect to the S&P MLP Index is the
licensing of the Index and certain trademarks, service marks and/or
trade names of S&P Dow Jones Indices and/or its licensors. The
S&P MLP Index is determined, composed and calculated by S&P
Dow Jones Indices without regard to UBS AG or the ETRACS 2xMonthly
Leveraged S&P MLP Index ETN. S&P Dow Jones Indices have no
obligation to take the needs of UBS AG or the owners of the ETRACS
2xMonthly Leveraged S&P MLP Index ETN into consideration in
determining, composing or calculating the S&P MLP Index.
S&P Dow Jones Indices are not responsible for and have not
participated in the determination of the prices, and amount of the
ETRACS 2xMonthly Leveraged S&P MLP Index ETN or the timing of
the issuance or sale of the ETRACS 2xMonthly Leveraged S&P MLP
Index ETN or in the determination or calculation of the equation by
which the ETRACS 2xMonthly Leveraged S&P MLP Index ETN is to be
converted into cash, surrendered or redeemed, as the case may be.
S&P Dow Jones Indices have no obligation or liability in
connection with the administration, marketing or trading of the
ETRACS 2xMonthly Leveraged S&P MLP Index ETN. There is no
assurance that investment products based on the S&P MLP Index
will accurately track index performance or provide positive
investment returns. S&P Dow Jones Indices LLC is not an
investment advisor. Inclusion of a security within an index is not
a recommendation by S&P Dow Jones Indices to buy, sell, or hold
such security, nor is it considered to be investment advice.
S&P DOW JONES INDICES DOES NOT GUARANTEE THE ADEQUACY,
ACCURACY, TIMELINESS AND/OR THE COMPLETENESS OF THE INDEX OR ANY
DATA RELATED THERETO OR ANY COMMUNICATION, INCLUDING BUT NOT
LIMITED TO, ORAL OR WRITTEN COMMUNICATION (INCLUDING ELECTRONIC
COMMUNICATIONS) WITH RESPECT THERETO. S&P DOW JONES INDICES
SHALL NOT BE SUBJECT TO ANY DAMAGES OR LIABILITY FOR ANY ERRORS,
OMISSIONS, OR DELAYS THEREIN. S&P DOW JONES INDICES MAKE NO
EXPRESS OR IMPLIED WARRANTIES, AND EXPRESSLY DISCLAIMS ALL
WARRANTIES, OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE
OR USE OR AS TO RESULTS TO BE OBTAINED BY UBS AG, OWNERS OF THE
ETRACS 2X MONTHLY LEVERAGED S&P MLP INDEX ETN, OR ANY OTHER
PERSON OR ENTITY FROM THE USE OF THE INDEX OR WITH RESPECT TO ANY
DATA RELATED THERETO. WITHOUT LIMITING ANY OF THE FOREGOING, IN NO
EVENT WHATSOEVER SHALL S&P DOW JONES INDICES BE LIABLE FOR ANY
INDIRECT, SPECIAL, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES
INCLUDING BUT NOT LIMITED TO, LOSS OF PROFITS, TRADING LOSSES, LOST
TIME OR GOODWILL, EVEN IF THEY HAVE BEEN ADVISED OF THE POSSIBLITY
OF SUCH DAMAGES, WHETHER IN CONTRACT, TORT, STRICT LIABILITY, OR
OTHERWISE. THERE ARE NO THIRD PARTY BENEFICIARIES OF ANY AGREEMENTS
OR ARRANGEMENTS BETWEEN S&P DOW JONES INDICES AND UBS AG, OTHER
THAN THE LICENSORS OF S&P DOW JONES INDICES.
UBS specifically prohibits the redistribution or reproduction of
this material in whole or in part without the prior written
permission of UBS and UBS accepts no liability whatsoever for the
actions of third parties in this respect.
© UBS 2016. The key symbol, UBS and ETRACS are among the
registered and unregistered trademarks of UBS. Other marks may be
trademarks of their respective owners. All rights reserved.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160209005511/en/
UBSMediaErica Chase, +1-212-713
1302erica.chase@ubs.comorInvestor+1-877-387 2275
UBS (NYSE:UBS)
Historical Stock Chart
From Aug 2024 to Sep 2024
UBS (NYSE:UBS)
Historical Stock Chart
From Sep 2023 to Sep 2024